Literature DB >> 22118347

Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men.

Daniel J Mazur1, Brian T Helfand, Kevin T McVary.   

Abstract

As men age, there is an increase in the frequency of pathologic diseases affecting the genitourinary tract. Most notable among these changes are the rising prevalence of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). The pathogenesis of these conditions seems to be multifactorial and includes age-related changes in the nervous system and neuroregulatory factors, such as nitric oxide and RhoA/Rho-kinase. Various pharmacologic agents that target these pathways, such as α-blockers and PDE-5is, underscore the contribution of neuroregulatory factors on the development of LUTS/BPH and ED.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118347     DOI: 10.1016/j.ucl.2011.09.005

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  6 in total

1.  Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies.

Authors:  Chaohui Gu; Naichun Zhou; Pratik Gurung; Yiping Kou; Yang Luo; Yidi Wang; Hui Zhou; Cheng Zhen; Jinjian Yang; Fengyan Tian; Guan Wu
Journal:  World J Urol       Date:  2019-06-17       Impact factor: 4.226

2.  The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Yunus Doğan; Fatih Uruç; Bekir Aras; Aytaç Şahin; Mithat Kıvrak; Ahmet Ürkmez; Numan Doğu Güner; Sabahattin Aydın
Journal:  Turk J Urol       Date:  2015-03

3.  Male Voiding Behavior: Insight from 19,824 At-Home Uroflow Profiles.

Authors:  Stephen J Summers; Joseph M Armstrong; Steven A Kaplan; Alex E Te; Alvin Le; Scott M Heiner; Angela P Presson; Guo Wei; James M Hotaling
Journal:  J Urol       Date:  2020-12-01       Impact factor: 7.450

4.  Alpha-Blocker Treatment Response in Men With Lower Urinary Tract Symptoms Based on Sympathetic Activity: Prospective, Multicenter, Open-Labeled, Observational Study.

Authors:  Sung Gon Park; Byung Ha Chung; Sung Won Lee; Jong Kwan Park; Kwangsung Park; Jun Cheon; Kyung Seop Lee; Hyung-Jee Kim; Do-Hwan Seong; Seung-June Oh; Sae Woong Kim; Ji Youl Lee; Seol Ho Choo; Jong Bo Choi
Journal:  Int Neurourol J       Date:  2015-06-29       Impact factor: 2.835

5.  The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men.

Authors:  Yi Lu; Shujun Fan; Yuxuan Song; Kang Liu; Kechong Zhou; Jiaqi Kang; Shangren Wang; Yongjiao Yang; Xiaoqiang Liu
Journal:  World J Urol       Date:  2020-11-03       Impact factor: 4.226

6.  Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms.

Authors:  Kang Hee Shim; Tae Woo Kim; Byung Ha Chung; Sung Won Lee; Jong Kwan Park; Kwangsung Park; Jun Cheon; Kyung Seop Lee; Hyung-Jee Kim; Do-Hwan Seong; Seung-June Oh; Sae Woong Kim; Ji Youl Lee; Seol Ho Choo; Jong Bo Choi
Journal:  Investig Clin Urol       Date:  2017-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.